🔎 Trials Near Me

Home › Eksema › Alabama › Birmingham

Pag-aaral pangklinika para sa Eksema sa Birmingham, AL

Isang pag-aaral para sa Eksema ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Birmingham. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema

Nagre-recruitPhase 3
  • Cahaba Dermatology & Skin Health Center, Birmingham
Edad 12 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07765888

First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis

Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
  • Cahaba Dermatology & Skin Health Center, LLC, Birmingham
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07527923

Roflumilast Cream 0.3% for Moderate to Severe Atopic Dermatitis

Nagre-recruitPhase 3
  • Arcutis Site 324, Birmingham
Edad 6 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07916480

A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema

Nagre-recruitPhase 3
  • AllerVie Clinical Research, Birmingham
  • Cahaba Dermatology & Skin Health Center, Birmingham
Edad 12 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07783425

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

Nagre-recruitPhase 3
  • Cahaba Dermatology & Skin Health Center, Birmingham
Edad 2 hanggang 11 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT06807281

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

Nagre-recruitPhase 2
  • Novartis Investigative Site, Birmingham
  • Novartis Investigative Site, Birmingham
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06947993

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

Nagre-recruitPhase 2
  • AllerVie Clinical Research, Birmingham
  • Cahaba Dermatology and Skin Health Center, Birmingham
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07599813

Pag-aaral para sa Eksema sa ibang lungsod

Iba pang pag-aaral sa Birmingham

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.